SB

Samsara BioCapital Portfolio holdings

AUM $489M
1-Year Est. Return 135.25%
This Quarter Est. Return
1 Year Est. Return
+135.25%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$729M
AUM Growth
+$208M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
47
New
Increased
Reduced
Closed

Top Buys

1
+$63.4M
2
+$36.4M
3
+$10.3M
4
PVLA
Palvella Therapeutics
PVLA
+$8.15M
5
OKUR
OnKure Therapeutics
OKUR
+$7.09M

Top Sells

1
+$50.8M
2
+$7.67M
3
+$6.39M
4
VRNA
Verona Pharma
VRNA
+$4.53M
5
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
+$3.84M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$243M 33.3%
5,612,896
-1,175,713
2
$63.7M 8.74%
4,415,689
3
$63.4M 8.7%
+2,768,520
4
$62.5M 8.57%
5,074,916
5
$39.3M 5.39%
1,717,127
+449,337
6
$36.4M 5%
+2,217,146
7
$28.5M 3.91%
986,981
-221,492
8
$25.7M 3.52%
3,266,498
9
$19.5M 2.67%
253,641
-100,000
10
$14.6M 2.01%
1,000,000
11
$12.5M 1.72%
584,642
12
$10.2M 1.4%
967,527
13
$9.66M 1.33%
172,647
14
$9.38M 1.29%
3,768,035
15
$8.63M 1.18%
588,816
16
$8.15M 1.12%
+679,486
17
$7.92M 1.09%
2,523,022
18
$7.09M 0.97%
+824,155
19
$7.02M 0.96%
2,442,352
20
$6.22M 0.85%
850,000
21
$5.91M 0.81%
2,385,060
+1,688,889
22
$5.55M 0.76%
6,130,268
23
$4.7M 0.64%
2,609,114
24
$4.53M 0.62%
97,625
-97,600
25
$4.33M 0.59%
1,562,500
1
2